 |
| Using a Nebulizer |
|
 |
|
|
| There are 3 common ways to take an inhaled medication:
|
- Nebulizer: a device that converts your medication into a fine mist. To use a nebulizer,
you breathe naturally through a mouthpiece
or facemask until all the medication has
been inhaled
- Metered Dose Inhaler (MDI):
a small, hand-held device that delivers
medication through a short measured burst.
You must be able to take in and hold a deep
breath in order to get all your medicine
- Dry Powder Inhaler (DPI):
a hand-held device that releases dry
medication into the lungs. You must be able
to take the medication in and hold a deep
breath
|
|
|
| Advantages of
nebulization |
|
| Nebulizers mix medicine with compressed air to create a fine mist that the patient breathes in through a facemask or mouthpiece.1 Nebulizers offer the advantage of delivering the drug directly into the lungs, and are often easier to coordinate for young children.
|
|
| For children, nebulization is one of the easiest and most effective ways to administer asthma medicine.2 Using appropriately sized masks that fit infants, or mouthpieces for older children and adults, patients simply breathe normally until all the medicine has been inhaled. Another advantage of nebulization, particularly for young children, is that it requires no special technique to get the medicine into the lungs. By contrast, MDIs require proper technique that may be hard for young children to master, and in many cases a significant portion of the medicine does not reach the child's lungs.3 |
|
|
| AccuNeb® (albuterol sulfate) Inhalation Solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease). |
 |
| Important Safety Information |
|
| In a clinical trial with AccuNeb® Inhalation Solution 0.63 mg, AccuNeb® Inhalation Solution 1.25 mg, and placebo, the most commonly reported adverse events were asthma exacerbations (11.1%, 13%, 8.5%), otitis media (0.9%, 4.3%, 0%), allergic reaction (3.4%, 0.9%, 1.7%), gastroenteritis (3.4%, 0.9%, 0.9%), and flu syndrome (2.6%, 2.6%, 1.7%). |
|
| Like other beta-adrenergic agonists, AccuNeb® Inhalation Solution can produce paradoxical bronchospasm, which may be life-threatening. AccuNeb® Inhalation Solution should be used with caution in patients with cardiovascular disorders and patients being treated with epinephrine, oral sympathomimetics, beta-blockers, MAOIs, or tricyclic antidepressants. |
|
| Please see Patient Prescribing Information. |
|
|
|
|
|
|
|
